New guidelines from the Endocrine Society address the information gap regarding dyslipidemia screening and cardiovascular risk assessment and management in endocrine diseases beyond diabetes and obesity. The guidelines, published in The Journal of Clinical Endocrinology & Metabolism, also provide recommendations on lipid management in thyroid disease, Cushing’s syndrome, disorders of growth hormone secretion, PCOS, menopause, ...
Lipid and CVD risk screening needed for all patients with endocrine diseases
By Mardi Chapman
5 Nov 2020